Follow
Shilpanjali Jesudason
Shilpanjali Jesudason
Royal Adelaide Hospital
Verified email at sa.gov.au
Title
Cited by
Cited by
Year
Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD
S Jesudason, BS Grace, SP McDonald
Clinical Journal of the American Society of Nephrology 9 (1), 143-149, 2014
1502014
Defining definitions: a Delphi study to develop a core outcome set for conditions of severe maternal morbidity
T Schaap, K Bloemenkamp, C Deneux‐Tharaux, M Knight, ...
BJOG: An International Journal of Obstetrics & Gynaecology 126 (3), 394-401, 2019
1052019
Pregnancy outcomes for kidney transplant recipients
ML Wyld, PA Clayton, S Jesudason, SJ Chadban, SI Alexander
American Journal of Transplantation 13 (12), 3173-3182, 2013
942013
Managing pregnancy in chronic kidney disease: improving outcomes for mother and baby
A Fitzpatrick, F Mohammadi, S Jesudason
International journal of women's health, 273-285, 2016
862016
Gastrointestinal symptoms in patients receiving dialysis: a systematic review
J Zuvela, C Trimingham, R Le Leu, R Faull, P Clayton, S Jesudason, ...
Nephrology 23 (8), 718-727, 2018
842018
Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease
AM Evans, RJ Faull, RL Nation, S Prasad, T Elias, SE Reuter, G Fornasini
Kidney international 66 (4), 1527-1534, 2004
802004
Developing consensus-based priority outcome domains for trials in kidney transplantation: a multinational Delphi survey with patients, caregivers, and health professionals
B Sautenet, A Tong, KE Manera, JR Chapman, AN Warrens, ...
Transplantation 101 (8), 1875-1886, 2017
752017
Perspectives on pregnancy in women with chronic kidney disease: systematic review of qualitative studies
A Tong, S Jesudason, JC Craig, WC Winkelmayer
Nephrology Dialysis Transplantation 30 (4), 652-661, 2015
742015
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ...
The Lancet 401 (10388), 1584-1594, 2023
682023
An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis
KE Manera, A Tong, JC Craig, J Shen, S Jesudason, Y Cho, B Sautenet, ...
Kidney international 96 (3), 699-710, 2019
682019
Perspectives on pregnancy in women with CKD: a semistructured interview study
A Tong, MA Brown, WC Winkelmayer, JC Craig, S Jesudason
American Journal of Kidney Diseases 66 (6), 951-961, 2015
632015
Pregnancy outcomes and impact of pregnancy on graft function in women after kidney transplantation
FA Mohammadi, M Borg, A Gulyani, SP McDonald, S Jesudason
Clinical transplantation 31 (10), e13089, 2017
582017
Manipulating human dendritic cell phenotype and function with targeted porous silicon nanoparticles
SO Stead, SJP McInnes, S Kireta, PD Rose, S Jesudason, ...
Biomaterials 155, 92-102, 2018
392018
The prevalence and evidence-based management of needle fear in adults with chronic disease: a scoping review
E Duncanson, RK Le Leu, L Shanahan, L Macauley, PN Bennett, ...
Plos one 16 (6), e0253048, 2021
332021
Differential effects of estrogen on corticosteroid-binding globulin forms suggests reduced cleavage in pregnancy
MA Nenke, A Zeng, EJ Meyer, JG Lewis, W Rankin, J Johnston, S Kireta, ...
Journal of the Endocrine Society 1 (3), 202-210, 2017
322017
The patient experience of kidney disease and pregnancy
S Jesudason, A Tong
Best Practice & Research Clinical Obstetrics & Gynaecology 57, 77-88, 2019
282019
Denosumab-induced severe hypocalcaemia in chronic kidney disease
R Jalleh, G Basu, R Le Leu, S Jesudason
Case Reports in Nephrology 2018, 2018
282018
Spontaneous, bilateral patellar tendon rupture in a woman with previous Achilles tendon rupture and systemic lupus erythematosus
S Prasad, A Lee, R Clarnette, R Faull
Rheumatology 42 (7), 905-906, 2003
272003
Recruitment and retention in clinical trials in chronic kidney disease: report from national workshops with patients, caregivers and health professionals
P Natale, T Gutman, M Howell, K Dansie, CM Hawley, Y Cho, AK Viecelli, ...
Nephrology Dialysis Transplantation 35 (5), 755-764, 2020
252020
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ...
The Lancet 402 (10417), 2077-2090, 2023
222023
The system can't perform the operation now. Try again later.
Articles 1–20